SEC Filings
ARK Holds 5.54% Of Prime Medicine Without A Bid To Influence Control
The investment manager reported more than 10 million shares in the developer of DNA-editing medicines.
SEC Filings
The investment manager reported more than 10 million shares in the developer of DNA-editing medicines.
SEC Filings
The new securities carry a 7.625% rate, while the older series targeted for repurchase carries 6.000%.
SEC Filings
The investment advisers and their managing partner reported authority over shares directly owned by advisory clients.
SEC Filings
Corbus is advancing a late-stage cancer trial alongside an early-stage obesity drug study.
SEC Filings
The investment manager certified that the holding was passive, with most shares attributed to its Capital Management subsidiary.
SEC Filings
The investment manager's disclosed US stock holdings rose to $17.4 billion even as its portfolio contained fewer positions.
SEC Filings
The investor exited Markel and Everpure and added Casella and Modine, ending September with a $1.6 billion disclosed stock portfolio.
SEC Filings
Donald Smith & Co.'s clients retain authority over dividends and sale proceeds and can revoke the adviser's investment discretion.
SEC Filings
Investment adviser Donald Smith & Co. reported the holding Friday; its institutional clients can revoke its discretionary authority.
SEC Filings
The investment adviser reported voting and sale authority over 3,825,096.02 shares as TKO prepares for Saudi events.
SEC Filings
The investment adviser reported sole voting authority over 1,682,288 shares, while clients can withdraw its investment discretion.
SEC Filings
The investment adviser manages the position, while its institutional clients retain authority over dividends and sale proceeds.